Hongkong XinRunde Chemical Co., Ltd

 

Reliable Manufacturer and Supplier of Top Quality Pharmaceutical Raw Material and Pharmaceutical Intermediate

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsPharmaceutical Intermediate

1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals

1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals

1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals
1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals

Large Image :  1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals Get Best Price

Product Details:

Place of Origin: CHINA
Brand Name: XRD
Certification: GMP
Model Number: 1890208-58-8

Payment & Shipping Terms:

Minimum Order Quantity: negotiable
Price: Negotiable
Packaging Details: 1-2 Kg / Aluminum Foil Bag, 25kg/ Drum, as Require
Delivery Time: 3-7 work days
Payment Terms: T/T, Western Union,Bitcoin
Supply Ability: 5000kg/year
Detailed Product Description
Purity: 99% Cas No.: 1890208-58-8
Product NamRopivacainee: Compound 7P Appearance: White Powder
Assay: 99% Compound 7P Grade: Pharmaceutical Grade
Storage: Cool Dried Storage Application: Pharmaceutical Raw Intermediates
High Light:

raw materials for pharma industry

,

intermediates in pharmaceuticals

CAS 1890208-58-8 Pharmaceutical Intermediate Nootropics powder 99% Compound 7P

 

 

 

Description:

 

Chemical Name: 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide ;2-(N-(2-methoxyphenyl)-4-methylphenylsulfonamido)-N-(4-methoxypyridin-3-yl)acetamide

CAS No.: 1890208-58-8

Reaxys Registry Number: 29568294
Molecular Formula: C22H23N3O5S
Molecular Weight: 441.508

Assay:99%min
InChI Key: NAXWKPFXCOBXLE-UHFFFAOYSA-N

Density(Predicted): 1.329±0.06 g/cm3 |Condition:Temp:20 Press:760Torr

 

Function:

 

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, compound 7p was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo.further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.

 

 

 

 

1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals 0

 

 

 

Packing:

 

1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals 1

 

 

 

 

CAS 1890208-58-8 Pharmaceutical Intermediate Nootropics powder 99% Compound 7P

 

 

Contact Details
Hongkong XinRunde Chemical Co., Ltd

Contact Person: bruce

Send your inquiry directly to us